You are here

  • Home
  • Archive
  • Volume 10, Issue Suppl 1
  • LSO-028 Predictors of de novo renal flares in systemic lupus erythematosus – time to revisit belimumab dose for extra-renal disease? Results from five phase III clinical trials of belimumab

Citation Tools

Article menu

Download PDFPDF

Short Oral Presentation
Short oral presentation session 5: lupus nephritis
LSO-028 Predictors of de novo renal flares in systemic lupus erythematosus – time to revisit belimumab dose for extra-renal disease? Results from five phase III clinical trials of belimumab

Download to a citation manager

Download the citation for this article by clicking on one of the following citation managers:

Cite this article as:
Parodis I, Lindblom J, Çetrez N, et al
LSO-028 Predictors of de novo renal flares in systemic lupus erythematosus – time to revisit belimumab dose for extra-renal disease? Results from five phase III clinical trials of belimumab
Lupus Science & Medicine 2023;10:doi: 10.1136/lupus-2023-KCR.69